Sebastian Wolf

MD, clinician scientist, computational hematology, R

[Sebastian Wolf @SWolfSci]

Proud to share our AML proteome paper in Cancer Cell. We report the discovery of Mito-AML proteome subtype that identifies clinical resistance to chemotherapy. Thanks for the great collaborative effort @labs_mann, @jayavelu_ak, @BuettnerFlo, @FCI_health. https://t.co/oq5duSGZiN

[Sebastian Wolf @SWolfSci]

@ASKubasch Herzlichen Glückwunsch!

[Universitätsmedizin Frankfurt @UK_Frankfurt]

Eingeschränkte Erreichbarkeit: Unsere #UKF-Kliniken und -Beschäftigten sind aktuell nicht per E-Mail erreichbar. Auch die Webseite steht nicht zur Verfügung. Wir sind aber telefonisch fur Euch da. Bitte habt Verständnis, wenn das etwas langer dauert als üblich.

[Sebastian Wolf @SWolfSci]

@StefBPhD @EHA_Hematology @young_eha Would have loved to meet you and treat you some Apfelwein! Wishing you a fantastic time at the meeting and enjoy your visit to Frankfurt!

[Jan-Henning Klusmann @JhKmann]

Join the fight against #AML! Our C³OMBAT-AML research unit is looking for a driven scientist to define aberrant epigenetic programs & resolve oncogenic networks. Use cutting-edge tech & work towards developing new therapies.
@FCI_health @goetheuni

https://t.co/lcsdpcVTaG

[Florian Buettner @BuettnerFlo]

Bioinformaticians, if you are searching for a new role where you can make an impact in the clinic, look no further: we have an open position in Frankfurt where you can help us bring the molecular tumor board to the next bioinformatics level: https://t.co/GGC2l5m1Ux

[Sebastian Wolf @SWolfSci]

Had an awesome couple of days visiting and learning at #ASH22 with this one @j_enssle. Looking forward to many more. Thanks @NOLA for having us. #leusm @FCI_health

[Stegmaier Lab @KStegmaier_DFCI]

Great DFCI party #ASH22 night 2

[HI-STEM - Cancer and Stem Cells in Heidelberg @hi_stem_lab]

Excited to share our latest manuscript on medRxiv by @DarjaK1 and @DrHHEncabo, a collaboration between the laboratories of Andreas Trumpp @hi_stem_lab and @DKFZ, Dominique Bonnet @TheCrick and Halvard Bönig (DRK Blutspendedienst).
https://t.co/VFxhnn7VYw #medRxiv.... 🧵1/8

[Carlos Balsalobre @DocBalsalobre]

How to explain Normal Distribution to a bro in the gym

[Sebastian Wolf @SWolfSci]

Thank you @Bioconductor and @wolfgangkhuber for a great week at #csama2022 with loads of interesting people and science!

[Sebastian Wolf @SWolfSci]

@DaphniGray Alles Gute!

[AML Hub @AML_Hub]

Congress| #EHA2022 @Daver_Leukemia, @MDAndersonNews reports on tolerability and efficacy data from a phase 1b trial of magrolimab + AZA in pts with TP53mut #AML unsuitable for intensive chemotherapy. Results showed good responses and encouraging OS #AMLsm #medicalcongress

[Cell Host & Microbe @cellhostmicrobe]

Rethinking healthy eating in light of gut microbiome: This review examines how diet-#microbiome-host interactions can validate, refine & innovate #dietary guidelines. Integration of microbiome science into #nutrition research will improve healthy eating https://t.co/XOYiskCSKF

[Florian Buettner @BuettnerFlo]

Come join us in Frankfurt as PhD student at the interface of machine learning and oncology!
https://t.co/5VxXveT2ZR
Work with Thomas Oellerich and me and use ML to make a difference in cancer research - one more week to apply!

Please RT

[Sebastian Wolf @SWolfSci]

@AndreMansoor Thank you for the wonderful explanation. However, in German we'd call this a 'Blickdiagnose' which is precisely what you said, a diagnosis that becomes imminent the moment you see it.

[Jan-Henning Klusmann @JhKmann]

Excited to share our prepublished work. For 14 years we have been working on the project to find out how #trisomy 21 drives #leukemia.

[Sebastian Wolf @SWolfSci]

@BReinfeld @labs_mann @jayavelu_ak @BuettnerFlo @FCI_health Hi Brad, thank you very much for your interest in our paper! I'm happy to share this information with you, just shoot me an email (contact details at https://t.co/qdOnBa5xEH)

[Sebastian Wolf @SWolfSci]

Proud to share our AML proteome paper in Cancer Cell. We report the discovery of Mito-AML proteome subtype that identifies clinical resistance to chemotherapy. Thanks for the great collaborative effort @labs_mann, @jayavelu_ak, @BuettnerFlo, @FCI_health. https://t.co/oq5duSGZiN

[Sebastian Wolf @SWolfSci]

@JhKmann @goetheuni Thank you so much! Looking foward to continue working together #AML

[Jayavelu AK @jayavelu_ak]

Our AML proteome paper is out in Cancer Cell. Here we report the discovery of Mito-AML proteome subtype that identifies clinical resistance to chemotherapy. Thanks for the great support @labs_mann and @SwolfSci @BuettnerFlo. https://t.co/grrgE2Dd9b